IntelligentMDx is pleased to announce that Dr. Phillip Moen, who joined the company in June, 2009 has been promoted to Director, Product Development
Dr Phillip Moen joined IntelligentMDx in June, 2009 and has a broad background in molecular and cellular diagnostic assay development, having held senior research and product development positions for several major Biotechnology companies including E.I DuPont de Nemours, Inc., NEN Life Sciences, Inc. (now PerkinElmer), and SeraCare Life Sciences, Inc. He has strong project management and product development skills in in-vitro diagnostics, having developed both FDA-cleared and CE-marked products under ISO 13485 guidelines.
IntelligentMDx is a commercial stage molecular diagnostics company that makes tests that are clinically impactful, competitively differentiated,and platform agnostic. We have product offerings for Seasonal/Pandemic Influenza, Bordetella, Immunocompromised and Infection Control including antimicrobial resistance screening. IntelligentMDx commercializes molecular diagnostic test solutions under FDA QSR, ISO 13485:2003 and IVDD regulations and guidances for use in clinical reference laboratories.